IE811891L - Treating insufficiencies in hematosis - Google Patents
Treating insufficiencies in hematosisInfo
- Publication number
- IE811891L IE811891L IE811891A IE189181A IE811891L IE 811891 L IE811891 L IE 811891L IE 811891 A IE811891 A IE 811891A IE 189181 A IE189181 A IE 189181A IE 811891 L IE811891 L IE 811891L
- Authority
- IE
- Ireland
- Prior art keywords
- active ingredient
- hematosis
- insufficiencies
- treating
- pharmaceutically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method of treating insufficiencies in hematosis, such as hypoxemia, cardiac insufficiency, and polyglobulia, involving treatment of a patient suffering from such insufficiency with the compound almitrine or a pharmaceutically-acceptable salt thereof in extremely low daily dosages, between 0.5 and 3 mg/kg orally or 0.05 to 0.3 mg/kg intravenously, an oral unit dosage form of the said active ingredient, containing between 20 and 70 mg of active ingredient together with a pharmaceutically-acceptable carrier or diluent, preferably about 50 mg of the active ingredient.
[US4364946A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8018074A FR2488509A1 (en) | 1980-08-18 | 1980-08-18 | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING ALMITRIN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE811891L true IE811891L (en) | 1982-02-18 |
| IE52095B1 IE52095B1 (en) | 1987-06-10 |
Family
ID=9245242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1891/81A IE52095B1 (en) | 1980-08-18 | 1981-08-18 | Pharmaceutical preparations for treating insufficiencies in haematosis |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4364946A (en) |
| AU (1) | AU550741B2 (en) |
| BE (1) | BE890011A (en) |
| CA (1) | CA1181694A (en) |
| CH (1) | CH650152A5 (en) |
| DE (1) | DE3132654A1 (en) |
| FR (1) | FR2488509A1 (en) |
| GB (1) | GB2082064B (en) |
| GR (1) | GR75328B (en) |
| IE (1) | IE52095B1 (en) |
| IT (1) | IT1171461B (en) |
| LU (1) | LU83556A1 (en) |
| NZ (1) | NZ198062A (en) |
| ZA (1) | ZA815664B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2660558B1 (en) * | 1990-04-05 | 1994-09-09 | Adir | USE OF ALMITRINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF MALARIA. |
| US8453522B2 (en) * | 2009-07-31 | 2013-06-04 | Mts Systems Corporation | Wind turbine drive train test assembly |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1256513A (en) * | 1968-10-02 | 1971-12-08 |
-
1980
- 1980-08-18 FR FR8018074A patent/FR2488509A1/en active Granted
-
1981
- 1981-08-13 IT IT49104/81A patent/IT1171461B/en active
- 1981-08-14 LU LU83556A patent/LU83556A1/en unknown
- 1981-08-17 GR GR65808A patent/GR75328B/el unknown
- 1981-08-17 NZ NZ198062A patent/NZ198062A/en unknown
- 1981-08-17 CA CA000383989A patent/CA1181694A/en not_active Expired
- 1981-08-17 ZA ZA815664A patent/ZA815664B/en unknown
- 1981-08-18 US US06/294,014 patent/US4364946A/en not_active Expired - Fee Related
- 1981-08-18 AU AU74277/81A patent/AU550741B2/en not_active Ceased
- 1981-08-18 CH CH5348/81A patent/CH650152A5/en not_active IP Right Cessation
- 1981-08-18 IE IE1891/81A patent/IE52095B1/en unknown
- 1981-08-18 BE BE0/205710A patent/BE890011A/en not_active IP Right Cessation
- 1981-08-18 GB GB8125188A patent/GB2082064B/en not_active Expired
- 1981-08-18 DE DE19813132654 patent/DE3132654A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CH650152A5 (en) | 1985-07-15 |
| ZA815664B (en) | 1982-08-25 |
| IT1171461B (en) | 1987-06-10 |
| IE52095B1 (en) | 1987-06-10 |
| NZ198062A (en) | 1983-12-16 |
| GR75328B (en) | 1984-07-13 |
| BE890011A (en) | 1982-02-18 |
| GB2082064B (en) | 1985-06-26 |
| FR2488509B1 (en) | 1984-11-23 |
| LU83556A1 (en) | 1982-04-14 |
| FR2488509A1 (en) | 1982-02-19 |
| AU550741B2 (en) | 1986-04-10 |
| GB2082064A (en) | 1982-03-03 |
| AU7427781A (en) | 1982-02-25 |
| DE3132654A1 (en) | 1982-06-24 |
| IT8149104A0 (en) | 1981-08-13 |
| CA1181694A (en) | 1985-01-29 |
| US4364946A (en) | 1982-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2213339A1 (en) | Method of treating adenosine depletion | |
| EP0379806A3 (en) | Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines | |
| AU2553992A (en) | Bone-growth-stimulating composition | |
| CA2015838A1 (en) | Method of topically treating acne vulgaris | |
| CA2024188A1 (en) | Method of treating premature ejaculation using sertraline | |
| MX9605023A (en) | Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances. | |
| MY106528A (en) | Method of treating impotence. | |
| CA2108903A1 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| JPS6438020A (en) | Therapy | |
| AU4385089A (en) | Method of treatment for interstitial cystitis | |
| CA2139385A1 (en) | Products containing g-csf and tnf binding protein | |
| JO1589B1 (en) | Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones | |
| IE811891L (en) | Treating insufficiencies in hematosis | |
| AU4827085A (en) | Method for treatment of antidiuresis employing serine derivatives | |
| JPS57106618A (en) | Anticancer agent consisting of polyprenyl compound | |
| IE832255L (en) | Treatment of herpes labialis. | |
| EP0093497A3 (en) | Anthelmintic treatment | |
| IE840977L (en) | Pharmaceutical preparations | |
| CA2103707A1 (en) | Treatment of non-small cell lung carcinoma | |
| WO1987003590A1 (en) | Medicament for the treatment of diseases of the liver | |
| IE56277B1 (en) | Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers | |
| PH16941A (en) | Analgesic potentiation | |
| CA2190952A1 (en) | Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection | |
| AU6133386A (en) | Composition for preparing a medicament for topical treatment of paradentium diseases | |
| ES8303297A1 (en) | New peptide, process for preparation thereof and use thereof. |